Adicet bio to participate in a fireside chat at the h.c. wainwright 2nd annual cell therapy virtual conference

Redwood city, calif. & boston--(business wire)--adicet bio, inc. (nasdaq: acet), a clinical stage biotechnology company discovering and developing allogeneic gamma delta t cell therapies for autoimmune diseases and cancer, today announced that chen schor, president and chief executive officer, will participate in a fireside chat at the h.c. wainwright 2nd annual cell therapy virtual conference being held march 26, 2024. details of the event are as follows: date: tuesday, march 26, 2024 time: 10.
ACET Ratings Summary
ACET Quant Ranking